Artrya Share Price and Company Fundamentals



Price
$3.46
Change
-0.190 (-5.205%)
52 week range
0.56 - 5.24

Last traded: Today at 5:10 AM

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.

Key Metrics

PE ratio

-

PB ratio

18.40

Dividend yield

-

Beta

0.55

Market cap

$548.37M

Enterprise value

$381.49M

Company profile

Industry / Sector Health Information Services / Healthcare
Website https://www.artrya.com
Mailing address 1257 Hay Street West Perth WA 6005 Australia
Phone / Fax 61 8 6478 7816 /

Dividends

More: Artrya Dividend history, yield and payout ratio

Dividend yield

-

Dividend amount

$-

Payout ratio

0.00%

5Y Avg. yield

-%

Artrya paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.AYA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

Company Executives

As of Feb 2026, following are the company executives and directors listed on Artrya.

Name Title Age Total Pay
Mr. Bernard William Ridgeway F.A.C.I.D. Executive Chair 72
Mr. John Konstantopoulos B.E. Co-Founder & CEO
Mr. Richard Mark Jarvis Chief Financial Officer 51
Phil Bowen Chief Operations Officer
Prof. Girish Dwivedi M.D. Chief Scientific Officer
Dr. Richard M. Stewart Chief Regulatory Affairs & Quality Officer
Ryan Athearn Head of Global Clinical Operations
Mr. Kevin Ronald Hart B.Com., B.Comm (Hons), C.A., F.C.A. Company Secretary 63

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-60660.00%

Return on assets

-48.66%

Return on equity

-86.14%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Artrya is 548.37M and its enterprise value is 381.49M. The enterprise value to revenue ratio of AYA is 13624.81. The enterprise value to EBITDA ratio of AYA is -23.53.

The AYA's stocks Beta value is 0.55 making it 45% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Artrya (AYA)

Artrya (ASX:AYA) Frequently Asked Questions

1. What is Artrya's Stock Symbol?

Artrya trades on ASX under the ticker symbol "AYA".

2. What is Artrya's stock price today?

One share of AYA stock can currently be purchased for approximately $3.46.

3. How can I contact Artrya?

Artrya's mailing address is 1257 Hay Street West Perth WA 6005 Australia. The company can be reached via phone at 61 8 6478 7816.

4. What is Artrya's official website?

The official website of Artrya is https://www.artrya.com.